Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-095987

ACORDA THERAPEUTICS INC · ACOR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Ron Cohen
Officer — President and CEO · Director
Period of report
Feb 4, 2016
Accepted (ET)
Feb 5, 2016 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 4, 2016M14,642$5.85A415,192D
Common StockF1Feb 4, 2016M4,005$6.00A419,197D
Common StockF1Feb 4, 2016M10,591$15.49A429,788D
Common StockF2holding———100,000IBeneficial Ownership in Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F1,F3$5.85Feb 4, 2016M14,642D—Mar 17, 2016Common Stock14,6420D
Employee Stock Option (right to buy)F1,F4$6.00Feb 4, 2016M4,005D—Feb 15, 2016Common Stock4,0050D
Employee Stock Option (right to buy)F1,F5$15.49Feb 4, 2016M10,591D—Dec 21, 2016Common Stock10,59140,172D

Explanation of responses